Germline variants of the genes involved in NF-kB activation are associated with the risk of COPD and lung cancer development

Authors

Division of Molecular Medicine, Rudjer Boskovic Institute, Zagreb, Croatia

Hopp Children’s Cancer Center (KiTZ), Heidelberg, Germany

Division of Pediatric Neurooncology German Cancer Research Center (DKFZ) German Cancer Consortium (DKTK), Heidelberg, Germany

Division of Pediatric Neurooncology German Cancer Research Center (DKFZ) German Cancer Consortium (DKTK), Heidelberg, Germany

Departments of Clinical Genetics, Lund University, Lund, Sweden

Department of Medical Biochemistry and Hematology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia

Clinical Department for Respiratory Diseases Jordanovac, University Hospital Zagreb, School of Medicine University of Zagreb, Zagreb, Croatia

Clinical Department for Respiratory Diseases Jordanovac, University Hospital Zagreb, School of Medicine University of Zagreb, Zagreb, Croatia

Clinical Department for Respiratory Diseases Jordanovac, University Hospital Zagreb, School of Medicine University of Zagreb, Zagreb, Croatia

Clinical Department for Respiratory Diseases Jordanovac, University Hospital Zagreb, School of Medicine University of Zagreb, Zagreb, Croatia

Hopp Children’s Cancer Center (KiTZ), Heidelberg, Germany

Division of Pediatric Neurooncology German Cancer Research Center (DKFZ) German Cancer Consortium (DKTK), Heidelberg, Germany

Division of Molecular Medicine, Rudjer Boskovic Institute, Zagreb, Croatia

Faculty of Dental Medicine and Health, University of Osijek, Osijek, Croatia